within Pharmacolibrary.Drugs.ATC.M;

model M03BX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 9.166666666666667e-05,
    adminDuration  = 600,
    adminMass      = 8 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.042,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005833333333333333,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M03BX05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Thiocolchicoside is a semi-synthetic muscle relaxant derived from the natural product colchicoside. It acts as a GABA-A receptor agonist and is used primarily for the symptomatic treatment of painful muscle spasms. Thiocolchicoside has been withdrawn or restricted in some countries due to concerns about genotoxicity, but remains approved and available in others for short-term use in acute muscle spasm management.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults following oral administration.</p><h4>References</h4><ol><li><p>Perucca, E, et al., &amp; Pifferi, G (1995). Comparative pharmacokinetics and bioavailability of two oral formulations of thiocolchicoside, a GABA-mimetic muscle relaxant drug, in normal volunteers. <i>European journal of drug metabolism and pharmacokinetics</i> 20(4) 301–305. DOI:<a href=&quot;https://doi.org/10.1007/BF03190249&quot;>10.1007/BF03190249</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8983937/&quot;>https://pubmed.ncbi.nlm.nih.gov/8983937</a></p></li><li><p>Sandouk, P, et al., &amp; Scherrmann, JM (1994). Single-dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers. <i>Biopharmaceutics &amp; drug disposition</i> 15(1) 87–92. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510150108&quot;>10.1002/bdd.2510150108</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8161719/&quot;>https://pubmed.ncbi.nlm.nih.gov/8161719</a></p></li><li><p>Artusi, M, et al., &amp; Junginger, HE (2003). Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. <i>International journal of pharmaceutics</i> 250(1) 203–213. DOI:<a href=&quot;https://doi.org/10.1016/s0378-5173(02)00545-8&quot;>10.1016/s0378-5173(02)00545-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12480286/&quot;>https://pubmed.ncbi.nlm.nih.gov/12480286</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M03BX05;
